Computational Oncology and Digital Twinning for Cancer Patients towards Precision Therapies

Event Date:
2025-12-04T16:00:00
2025-12-04T17:00:00
Event Location:
HENN 201
Speaker:
Arman Rahmim, University of British Columbia
Related Upcoming Events:
Department Colloquia
Intended Audience:
Everyone
Local Contact:

Georg Rieger (rieger@phas.ubc.ca) and Brett Gladman (gladman@astro.ubc.ca)

All are welcome to this event!

Event Information:

Abstract: 
In this talk, we will elaborate on the emerging paradigm of digital twinning for cancer patients and application of virtual therapies for identification of optimal therapies, towards personalization of treatments. We will particularly focus on the exciting paradigm of theranostics and novel applications in computational oncology. We will discuss role of advanced computational models including physiologically based pharmacokinetic (PBPK) models, and discuss efforts to identify and tackle barriers to adoption of such advanced tools in the clinic.

Bio:


Dr. Rahmim is Professor at the UBC Departments of Physics & Astronomy and Radiology, as well as Distinguished Scientist and Provincial Medical Imaging Physicist at BC Cancer. He received his MSc in condensed matter physics and PhD in medical imaging physics at UBC. He was then recruited by Johns Hopkins University (JHU), leading the high-resolution brain PET imaging physics program and pursuing research at the JHU Departments of Radiology and Electrical Engineering. In 2018, he was recruited back to Vancouver, where his laboratory (Qurit.ca) pursues research in molecular imaging & therapy. He has published a book and over 320 journal articles, and delivered more than 200 invited lectures worldwide. He also hosts the Molecular Imaging & Therapy YouTube channel to help disseminate learning for a wide worldwide audience including students, residents, fellows and technologists. He is Scientific Lead of the BC Cancer Medical Imaging Core (CanMIC) Lab, aiming to translate state-of-the-art imaging solutions to clinical trials and research. Additionally, he is Co-Founder of Ascinta Technologies, working to develop easy-to-use, adaptable, and AI-enabled solutions for theranostics and radiopharmaceutical therapies. Dr. Rahmim was awarded in 2022 the Presidential Distinguished Service Award by the Society of Nuclear Medicine & Molecular Imaging (SNMMI) for significant contributions to the field of nuclear medicine & molecular imaging, and in 2025 the SNMMI Edward Hoffman Memorial Award for outstanding contributions to computational nuclear medicine research, best-practice, training and education.

 

Learn More:

Add to Calendar 2025-12-04T16:00:00 2025-12-04T17:00:00 Computational Oncology and Digital Twinning for Cancer Patients towards Precision Therapies Event Information: Abstract: In this talk, we will elaborate on the emerging paradigm of digital twinning for cancer patients and application of virtual therapies for identification of optimal therapies, towards personalization of treatments. We will particularly focus on the exciting paradigm of theranostics and novel applications in computational oncology. We will discuss role of advanced computational models including physiologically based pharmacokinetic (PBPK) models, and discuss efforts to identify and tackle barriers to adoption of such advanced tools in the clinic. Bio: Dr. Rahmim is Professor at the UBC Departments of Physics & Astronomy and Radiology, as well as Distinguished Scientist and Provincial Medical Imaging Physicist at BC Cancer. He received his MSc in condensed matter physics and PhD in medical imaging physics at UBC. He was then recruited by Johns Hopkins University (JHU), leading the high-resolution brain PET imaging physics program and pursuing research at the JHU Departments of Radiology and Electrical Engineering. In 2018, he was recruited back to Vancouver, where his laboratory (Qurit.ca) pursues research in molecular imaging & therapy. He has published a book and over 320 journal articles, and delivered more than 200 invited lectures worldwide. He also hosts the Molecular Imaging & Therapy YouTube channel to help disseminate learning for a wide worldwide audience including students, residents, fellows and technologists. He is Scientific Lead of the BC Cancer Medical Imaging Core (CanMIC) Lab, aiming to translate state-of-the-art imaging solutions to clinical trials and research. Additionally, he is Co-Founder of Ascinta Technologies, working to develop easy-to-use, adaptable, and AI-enabled solutions for theranostics and radiopharmaceutical therapies. Dr. Rahmim was awarded in 2022 the Presidential Distinguished Service Award by the Society of Nuclear Medicine & Molecular Imaging (SNMMI) for significant contributions to the field of nuclear medicine & molecular imaging, and in 2025 the SNMMI Edward Hoffman Memorial Award for outstanding contributions to computational nuclear medicine research, best-practice, training and education.   Learn More: About Dr. Rahmim: Arman Rahmim - UBC - SBME About Theranostics: Theranostics - Wikipedia Watch this video, "What is Theranostics?" Watch more videos on the Molecular Imaging & Therapy channel on Youtube: Molecular Imaging & Therapy - YouTube  Event Location: HENN 201